Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.
A meta-analysis of studies on children and adolescents with ADHD found that they are at an increased risk of depression and ...
74-year-old Jennifer Brown, who is currently participating in the NorAD clinical trial of extended-release guanfacine as an add-on to standard cholinesterase drugs for Alzheimer's, said trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback